News & Analysis on Clinical Trial Services & Contract Research And Development
After two difficult years, there are more signals in 2004 that trends are turning in the economic situation of German biotechnology companies, according to Prof Peter Stadler, chairman of the German Association of Biotechnology Industries (DIB).
Niro Pharma Systems is launching a new tablet coating system that promises to achieve a step forward in the evenness of tablet coating and make the production of small batches for R&D more cost effective.
A subsidiary of Switzerland's Serono has filed a lawsuit alleging that gene activation technology used in the production of Transkaryotic Therapies' biological drugs contravenes a US patent.